West Virginia Code of State Rules
Agency 69 - Health And Human Resources
Title 69 - LEGISLATIVE RULE DEPARTMENT OF HEALTH AND HUMAN RESOURCES
Series 69-11 - Medication-Assisted Treatment - Opioid Treatment Programs
Section 69-11-24 - Orientation

Current through Register Vol. XLI, No. 38, September 20, 2024

24.1. Every person admitted to a MAT program shall receive program orientation. The orientation shall be made verbally at the earliest opportunity at which the patient is stable and capable of understanding and retaining the information presented. Information provided in the orientation shall be given to the patient in writing at the time the decision is made to admit the patient, regardless of his or her condition, and shall include a formal agreement of informed consent to be signed by the patient.

24.2. Orientation shall include the following:

24.2.a. An explanation of the rights and responsibilities of the patient.

24.2.b. An explanation of the patient's right to file a grievance and applicable appeal procedures.

24.2.c. An explanation of the services and activities provided by the MAT program, either onsite or by referral, including:
24.2.c.1. Expectations and rules;

24.2.c.2. Hours of operation;

24.2.c.3. Access to after-hours services;

24.2.c.4. Confidentiality policy;

24.2.c.5. Drug screening and random drug-testing policies;

24.2.c.6. Sanctions, restrictions and other penalties;

24.2.c.7. Interventions;

24.2.c.8. Incentives; and

24.2.c.9. Various discharge criteria, including, but not limited to, administrative and medical withdrawal policies and procedures.

24.2.d. An explanation about obtaining reports from the Controlled Substances Monitoring Program database; how the reports are used to treat and monitor the patient and the requirement that the reports be maintained in the patient files.

24.2.e. An explanation of any and all financial obligations of the patient; all fees charged by the MAT program; and any financial arrangements for services provided by the MAT program, including the requirements stated in W. Va. Code § 16-5Y-5(e).

24.2.f. Familiarization with the MAT program facility and premises.

24.2.g. A description of the MAT program's policies regarding:
24.2.g.1. Use of alcohol on or prior to entering the facility and premises;

24.2.g.2. Smoking;

24.2.g.3. Illicit or licit drugs brought into the program or onto the premises; and

24.2.g.4. Weapons brought into the program or onto the premises.

24.2.h. Identification of the counselor assigned to the patient and contact information for that counselor.

24.2.i. A copy of the MAT program rules identifying the following:
24.2.i.1. Any restrictions the program may place on the patient;

24.2.i.2. Events, behaviors or attitudes that may lead to the loss of rights or privileges for the patient; and

24.2.i.3. Means by which the patient may regain rights or privileges that have been restricted;

24.2.j. An explanation of the purpose and process of the initial and subsequent physical and biopsychosocial assessments;

24.2.k. A description of how the individualized treatment plan of care and coordination of care agreement will be developed and the patient's expected participation in the plan of care; and

24.2.l. An explanation of alternative methods that are available for treatment of substance use disorder, whether offered by the program or not, and the potential benefits and risks.

24.3. Upon admission, each patient shall receive the following written information:

24.3.a. Signs and symptoms of overdose and when, where and how to seek emergency assistance;

24.3.b. A formal agreement of informed consent to be signed by the patient;

24.3.c. A signed copy the coordination of care agreement;

24.3.d. Patient's rights;

24.3.e. Confidentiality policies;

24.3.f. The program's processes for dispensing medication; and

24.3.g. Information on alternative methods available for treatment of substance use disorder and the potential benefits and risks. The state opioid treatment authority is responsible for providing informational materials to be used in discussing alternative treatments.

24.4. As soon as the patient is stable and capable of understanding, the patient shall receive group or individual education on the following:

24.4.a. Medication administration, including methods of dispensing and dosage restrictions;

24.4.b. The nature of substance use disorder including the great likelihood that substance use disorder is a relapsing disease and is likely to have grave medical and social consequences if not treated on an ongoing basis;

24.4.c. The anticipated benefits of treatment;

24.4.d. The nature of the recovery process;

24.4.e. HIV spectrum and other infectious diseases;

24.4.f. Potential drug interactions;

24.4.g. Self-help groups;

24.4.h. Medical issues related to detoxification from medication-assisted treatment medications;

24.4.i. The special risk of withdrawal from the medication-assisted treatment medication prescribed to the individual patient and detoxification to pregnant women and the fetus, as appropriate;

24.4.j. Characteristics of the medications administered or prescribed by the program;

24.4.k. Drug safety issues;

24.4.l. Dispensing procedures; and

24.4.m. Side effects of medications administered or prescribed by the program.

24.5. Documentation that the patient has completed the orientation training shall be completed and signed by the patient and maintained in the patient's chart and individualized treatment plan of care.

Disclaimer: These regulations may not be the most recent version. West Virginia may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.